379 related articles for article (PubMed ID: 16935916)
21. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T
J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
Szántó A; Csípo I; Zeher M
J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
[No Abstract] [Full Text] [Related]
24. The accuracy of the anti-α-fodrin antibody test for diagnosis of Sjögren's syndrome: a meta-analysis.
Hu Q; Wang D; Chen W
Clin Biochem; 2013 Oct; 46(15):1372-6. PubMed ID: 23639676
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.
Willeke P; Schlüter B; Schotte H; Domschke W; Gaubitz M; Becker H
Semin Arthritis Rheum; 2009 Dec; 39(3):197-202. PubMed ID: 18571695
[TBL] [Abstract][Full Text] [Related]
26. Low sensitivity of anti-alpha-fodrin antibodies in patients with primary Sjögren's syndrome.
Bizzaro N; Villalta D; Tonutti E
J Rheumatol; 2004 Nov; 31(11):2310-1; author reply 2311. PubMed ID: 15517652
[No Abstract] [Full Text] [Related]
27. Epitope mapping of anti-alpha-fodrin autoantibody in juvenile Sjögren's syndrome: difference in major epitopes between primary and secondary cases.
Shiari R; Kobayashi I; Toita N; Hatano N; Kawamura N; Okano M; Hayashi Y; Kobayashi K; Ariga T
J Rheumatol; 2006 Jul; 33(7):1395-400. PubMed ID: 16821274
[TBL] [Abstract][Full Text] [Related]
28. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
He J; Fang W; Li ZG
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
[TBL] [Abstract][Full Text] [Related]
29. [Establishment of Sjögren's syndrome models by immunization with alpha-Fodrin: experiment with mice].
He J; Wang H; Zhao JX; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2360-3. PubMed ID: 19087701
[TBL] [Abstract][Full Text] [Related]
30. [Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity].
He J; Zhao JX; Wang H; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):625-9. PubMed ID: 18646720
[TBL] [Abstract][Full Text] [Related]
31. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
Turkçapar N; Olmez U; Tutkak H; Duman M
Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to alpha-fodrin derived peptide in Sjögren's syndrome.
He J; Chen QL; Li ZG
Ann Rheum Dis; 2006 Apr; 65(4):549-50. PubMed ID: 16531552
[No Abstract] [Full Text] [Related]
33. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
34. The role of interleukin-10 promoter polymorphisms in primary Sjogren's syndrome.
Willeke P; Gaubitz M; Schotte H; Becker H; Domschke W; Schlüter B
Scand J Rheumatol; 2008; 37(4):293-9. PubMed ID: 18612930
[TBL] [Abstract][Full Text] [Related]
35. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.
Kahaly GJ; Bang H; Berg W; Dittmar M
Clin Exp Immunol; 2005 Apr; 140(1):166-72. PubMed ID: 15762888
[TBL] [Abstract][Full Text] [Related]
36. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
37. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
[TBL] [Abstract][Full Text] [Related]
38. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
[TBL] [Abstract][Full Text] [Related]
39. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
[TBL] [Abstract][Full Text] [Related]
40. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
